Xoma Limited: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	57
ISBN Number	not applicable
Product Code	DAT09431

Price

£265.00
approximately: $521 | €337

PRINT £265 ($521 | €337)

Order above formats by FAX

Summary

Introduction

XOMA is a biopharmaceutical company focusing on the discovery and development of therapeutic antibodies for the treatment of cancer and immune diseases. The company has a broad technology platform and a fully integrated product development infrastructure for antibodies and other biologics.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

XOMA's technological platform makes the company unique from its competitors. The company's marketed product, Lucentis was developed using its BCE technology and XOMA 052 is the first candidate being developed using another proprietary technology, Human Engineered (HE) technology.

The company derives its revenues from contract, licensing, collaboration and royalties. These include upfront and milestone payments related to the outlicensing agreement with Merck & Co as well as from contracts entered with SPRI, Taligen, AVEO and NIAID, Genentech and Novartis.

During 2006-2010, XOMA's revenues are expected to grow at a CAGR of 39% rising from $29 million to $110 million, over the period 2006-2010, XOMA's biggest contributor to sales growth out to 2010 will be from contract, license and collaboration, forecasted to grow at a CAGR of 43% from $19 million in 2006 to $81 million in 2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Geographic Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Discovery and Product Development
- Manufacturing
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: XOMA - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: XOMA - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: XOMA- Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: XOMA- Key Facts
- Table 2: XOMA - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: XOMA - Key Events Impacting Share Price Performance
- Table 4: XOMA - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: XOMA - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 6: XOMA - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: XOMA - Cash Flow, 2002-2006 ($ Mn)
- Table 8: XOMA - Revenue Breakdown by Division, 2002-2006 ($ Mn)
- Table 9: XOMA - Geographic Breakdown, 2002-2006 ($ Mn)
- Table 10: XOMA - Marketed Products
- Table 11: XOMA - in-house Pipeline Products
- Table 12: XOMA - Collaborative Pipeline Products
- Table 13: XOMA - Forecast Sales, 2006-2010 ($ Mn)
- Table 14: XOMA - Key Competitors
- Table 15: XOMA - Key Suppliers
- Table 16: XOMA - Key Clients
- Table 17: XOMA - Key Shareholders
- Table 18: XOMA - SWOT Analysis Summary
- Table 19: XOMA - Value Chain Analysis
- Table 20: XOMA - Scorecard
- Table 21: XOMA - Key Employees
- Table 22: XOMA - Financial and Operational Overview